Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ITRI-126 |
Trade Name | |
Synonyms | |
Drug Descriptions |
ITRI-126 is an androgen receptor (AR) degrader containing an AR N-terminal binding region linked to a CRBN E3 ligase-binding moiety, which induces proteasomal degradation of full-length AR and ligand-binding domain truncated AR variants, potentially leading to tumor growth inhibition (PMID: 36893587). |
DrugClasses | Hormone - Anti-androgens 54 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Enzalutamide + ITRI-126 | Enzalutamide ITRI-126 | 0 | 0 |
ITRI-126 | ITRI-126 | 0 | 0 |